Literature DB >> 2015976

Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients.

P C Butler1, R A Rizza.   

Abstract

Excessive amounts of glucose enter the systemic circulation when patients with non-insulin-dependent diabetes mellitus (NIDDM) eat a carbohydrate-containing meal. To determine the contribution of hepatic glucose cycling (defined as the net effect of glucose/glucose-6-phosphate cycling and uptake and release of glucose from hepatic glycogen) to postprandial hyperglycemia, diabetic, glucose-intolerant, and nondiabetic subjects were fed mixed meals. The meal contained both [2-3H]glucose (an isotope that is extensively detritiated during hepatic glucose cycling) and [6-3H]glucose (an isotope that is not detritiated during hepatic glucose cycling). Of the 50 g of carbohydrate contained in the meal, approximately 4-8 g underwent hepatic glucose cycling. Although total cycling of ingested glucose did not differ between diabetic, glucose-intolerant, and nondiabetic subjects (361 +/- 67 vs. 494 +/- 106 vs. 322 +/- 44 mumol.kg-1.5 h-1, respectively), the data suggested that hepatic cycling was increased in the diabetic and glucose-intolerant individuals but not in the nondiabetic subjects during the first 2 h after eating. Hepatic cycling during the first 2 h after eating was correlated with the prevailing glucagon concentration (r = 0.6, P less than 0.01) and increased (P less than 0.05) as hepatic glucose release increased. Hepatic glucose cycling had a marked effect on the measurement of so-called initial splanchnic glucose uptake. Nevertheless, however measured, initial splanchnic glucose uptake was not decreased and, if anything, was increased in diabetic and glucose-intolerant patients. Integrated postprandial hepatic glucose release increased (r less than 0.01) with the severity of fasting hyperglycemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015976

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Glucagon secretion in relation to insulin sensitivity in healthy subjects.

Authors:  B Ahrén
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

2.  Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.

Authors:  A Basu; A Alzaid; S Dinneen; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 3.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

4.  Modeling the pancreatic α-cell: dual mechanisms of glucose suppression of glucagon secretion.

Authors:  Margaret Watts; Arthur Sherman
Journal:  Biophys J       Date:  2014-02-04       Impact factor: 4.033

5.  Association between allelic variants in the glucagon-like peptide 1 and cholecystokinin receptor genes with gastric emptying and glucose tolerance.

Authors:  Bradley Anderson; Paula Carlson; Marcello Laurenti; Adrian Vella; Michael Camilleri; Anshuman Desai; Kelly Feuerhak; Adil E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2019-11-05       Impact factor: 3.598

6.  Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans.

Authors:  Anu Sharma; Ron T Varghese; Meera Shah; Chiara Dalla Man; Claudio Cobelli; Robert A Rizza; Kent R Bailey; Adrian Vella
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

7.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

8.  Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.

Authors:  Robert A Rizza
Journal:  Diabetes       Date:  2010-08-12       Impact factor: 9.461

9.  Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.

Authors:  KyeongJin Kim; Dongryeol Ryu; Paola Dongiovanni; Lale Ozcan; Shruti Nayak; Beatrix Ueberheide; Luca Valenti; Johan Auwerx; Utpal B Pajvani
Journal:  Gastroenterology       Date:  2017-08-30       Impact factor: 22.682

10.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.